Last update 21 Nov 2024

PNB-001

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
CCKA x CCKB
Mechanism
CCKA antagonists(Cholecystokinin A receptor antagonists), CCKB antagonists(Cholecystokinin B receptor antagonists)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesDigestive System Disorders+ [2]
Active Indication
COVID-19Inflammatory Bowel DiseasesColitis, Ulcerative+ [2]
Inactive Indication-
Originator Organization
PNB Vesper Life Sciences Pvt. Ltd
Active Organization
PNB Vesper Life Sciences Pvt. Ltd
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC18H16ClNO2
InChIKeyDXVXKGRKAPTSKZ-UHFFFAOYSA-N
CAS Registry1528760-09-9

Related

5
Clinical Trials associated with PNB-001
CTRI/2022/10/046658 / RecruitingPhase 2
A Phase II, Multicenter, Randomized, Double-blind, Placebo controlled Clinical study toevaluate efficacy and safety of PNB-001 as an adjunct to Mesalamine compared toMesalamine alone in Subjects with Inflammatory bowel disease
CTRI/2021/09/036411 / RecruitingPhase 3
A Phase III, Randomized, Open Label, Multicentric, Clinical Study to Evaluate the Efficacy and Safety of PNB-001 as an Adjunct to Standard of Care Compared to Standard of Care Alone in Treatment of Patients with Moderate COVID-19 Infection
CTRI/2020/10/028423 / CompletedPhase 2
A Randomized, Open label Clinical Study to Evaluate Efficacy and Safety of PNB-001 in Patients with moderate COVID-19 Infection.
100 Clinical Results associated with PNB-001
Login to view more data
100 Translational Medicine associated with PNB-001
Login to view more data
100 Patents (Medical) associated with PNB-001
Login to view more data
100 Deals associated with PNB-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 3
IN
PNB Vesper Life Sciences Pvt. Ltd
02 Aug 2022
Inflammatory Bowel DiseasesPhase 3
IN
PNB Vesper Life Sciences Pvt. Ltd
02 Aug 2022
Colitis, UlcerativePhase 2
IN
PNB Vesper Life Sciences Pvt. Ltd
28 Oct 2022
Crohn DiseasePhase 2
IN
PNB Vesper Life Sciences Pvt. Ltd
28 Oct 2022
Inflammatory painPhase 2
IN
PNB Vesper Life Sciences Pvt. Ltd
02 Aug 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free